ProShare Advisors’s Agios Pharmaceuticals AGIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $457K | Sell |
|
|||||
|
2025
Q1 | $434K | Sell |
|
|||||
|
2024
Q4 | $612K | Buy |
|
|||||
|
2024
Q3 | $624K | Buy |
|
|||||
|
2024
Q2 | $472K | Sell |
|
|||||
|
2024
Q1 | $407K | Buy |
|
|||||
|
2023
Q4 | $284K | Buy |
|
|||||
|
2023
Q3 | $269K | Buy |
|
|||||
|
2023
Q2 | $306K | Buy |
|
|||||
|
2023
Q1 | $236K | Sell |
|
|||||
|
2022
Q4 | $325K | Buy |
|
|||||
|
2022
Q3 | $300K | Sell |
|
|||||
|
2022
Q2 | $251K | Sell |
|
|||||
|
2022
Q1 | $497K | Sell |
|
|||||
|
2021
Q4 | $687K | Sell |
|
|||||
|
2021
Q3 | $994K | Sell |
|
|||||
|
2021
Q2 | $1.59M | Buy |
|
|||||
|
2021
Q1 | $553K | Sell |
|
|||||
|
2020
Q4 | $508K | Sell |
|
|||||
|
2020
Q3 | $425K | Buy |
|
|||||
|
2020
Q2 | $641K | Buy |
|
|||||
|
2020
Q1 | $372K | Sell |
|
|||||
|
2019
Q4 | $774K | Sell |
|
|||||
|
2019
Q3 | $555K | Sell |
|
|||||
|
2019
Q2 | $917K | Sell |
|
|||||
|
2019
Q1 | $1.48M | Buy |
|
|||||
|
2018
Q4 | $978K | Sell |
|
|||||
|
2018
Q3 | $1.96M | Buy |
|
|||||
|
2018
Q2 | $2.14M | Sell |
|
|||||
|
2018
Q1 | $2.27M | Buy |
|
|||||
|
2017
Q4 | $1.57M | Sell |
|
|||||
|
2017
Q3 | $1.89M | Buy |
|
|||||
|
2017
Q2 | $1.32M | Buy |
|
|||||
|
2017
Q1 | $1.36M | Sell |
|
|||||
|
2016
Q4 | $1.18M | Buy |
|
|||||
|
2016
Q3 | $1.32M | Sell |
|
|||||
|
2016
Q2 | $1.22M | Buy |
|
|||||
|
2016
Q1 | $1.16M | Sell |
|
|||||
|
2015
Q4 | $2.03M | Buy |
|
|||||
|
2015
Q3 | $2.08M | Sell |
|
|||||
|
2015
Q2 | $3.31M | Sell |
|
|||||
|
2015
Q1 | $3.09M | Buy |
|
|||||
|
2014
Q4 | $2.93M | Buy |
|
|||||
|
2014
Q3 | $1.42M | Sell |
|
|||||
|
2014
Q2 | $1.25M | Sell |
|
|||||
|
2014
Q1 | $1.21M | Buy |
|
|||||
|
2013
Q4 | $339K | Buy |
|